Cellosaurus cell line DH-My6 (CVCL

Cellosaurus DH-My6 (CVCL_WV40)

[Text version]

Cell line name

DH-My6

Accession

CVCL_WV40

Resource Identification Initiative

To cite this cell line use: DH-My6 (RRID:CVCL_WV40)

Comments

Population: Japanese.
Doubling time: 20 hours (PubMed=30323893).
Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.

Sequence variations

Gene fusion; HGNC; HGNC:1001; BCL6 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL6 (PubMed=30323893).
Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=30323893).

Disease

High grade B-cell lymphoma with MYC and BCL2 or BCL6 rearrangements (NCIt: C125904)
High grade B-cell lymphoma with MYC and/or BCL2 and/or BCL6 rearrangement (ORDO: Orphanet_480541)

Species of origin

Homo sapiens (Human) (NCBI Taxonomy: 9606)

Sex of cell

Male

Age at sampling

54Y

Category

Cancer cell line

STR profile

Source(s): PubMed=30323893

Markers:

Amelogenin	X,Y
CSF1PO	12
D5S818	10,12
D7S820	10,12
D13S317	8
D16S539	12,13
D21S11	30
TH01	6,7
TPOX	8
vWA	14,17

Publications

PubMed=30323893; DOI=10.18632/oncotarget.26060; PMCID=PMC6173362
Kikuchi H., Higuchi T., Hashida Y., Taniguchi A., Kamioka M., Taguchi T., Yokoyama A., Murakami I., Fujieda M., Daibata M.
Generation and characteristics of a novel 'double-hit' high grade B-cell lymphoma cell line DH-My6 with MYC/IGH and BCL6/IGH gene arrangements and potential molecular targeted therapies.
Oncotarget 9:33482-33499(2018)

Cross-references

Encyclopedic resources

Wikidata; Q93526724

Entry history

Entry creation

05-Jul-2019

Last entry update

19-Dec-2024

Version number